CYTARABINE (cytarabine/PF)
PYRIMIDINE ANALOGS·ACUTE LYMPHOID LEUKEMIA·+4
FRESENIUS KABI
Indication
Meningeal leukemia
Meningeal leukemia, also referred to as leukemic meningitis or leukemic leptomeningitis, is a serious complication characterized by the metastatic infiltration of leukemic cells into the leptomeninges and cerebrospinal fluid of the central nervous system. Read more about Meningeal leukemia
29 drugs 21 manufacturers
Drugs that treat it
Common Meningeal leukemia therapies.
METHOTREXATE (methotrexate sodium/PF)
ANTIPSORIATICS·OSTEOSARCOMA OF BONE·+12
Hikma Pharmaceuticals USA
Filter & compare in the drug finder →Opens the drug finder with Meningeal leukemia preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMeningeal leukemia, also referred to as leukemic meningitis or leukemic leptomeningitis, is a serious complication characterized by the metastatic infiltration of leukemic cells into the leptomeninges and cerebrospinal fluid of the central nervous system.
While it can emerge in any acute or chronic leukemia, it most frequently affects pediatric and adult patients with acute lymphoblastic leukemia and high-risk acute myeloid leukemia.
Pathophysiologically, leukemic blasts cross the blood-brain or blood-cerebrospinal fluid barrier to seed the subarachnoid space, leading to meningeal inflammation, disrupted cerebrospinal fluid dynamics, and potential cranial nerve involvement.
Clinically, this state manifests with features of increased intracranial pressure and neuroaxis dysfunction, including headaches, nausea, vomiting, altered mental status, seizures, and focal neurological deficits.
- cancer.gov
Meningeal leukemia, also referred to as leukemic meningitis or leukemic leptomeningitis, is a serious complication characterized by the metastatic infiltration of leukemic cells into the leptomeninges and cerebrospinal fluid of the central nervous system Pathophysiologically, leukemic blasts cross the blood-brain or blood-cerebrospinal fluid barrier to seed the subarachnoid space, leading to meningeal inflammation, disrupted cerebrospinal fluid dynamics, and potential cranial nerve involvement
- ucsd.edu
Meningeal leukemia, also referred to as leukemic meningitis or leukemic leptomeningitis, is a serious complication characterized by the metastatic infiltration of leukemic cells into the leptomeninges and cerebrospinal fluid of the central nervous system While it can emerge in any acute or chronic leukemia, it most frequently affects pediatric and adult patients with acute lymphoblastic leukemia and high-risk acute myeloid leukemia Pathophysiologically, leukemic blasts cross the blood-brain or b...
- nih.gov
While it can emerge in any acute or chronic leukemia, it most frequently affects pediatric and adult patients with acute lymphoblastic leukemia and high-risk acute myeloid leukemia
- qeios.com
While it can emerge in any acute or chronic leukemia, it most frequently affects pediatric and adult patients with acute lymphoblastic leukemia and high-risk acute myeloid leukemia
- nih.gov
Pathophysiologically, leukemic blasts cross the blood-brain or blood-cerebrospinal fluid barrier to seed the subarachnoid space, leading to meningeal inflammation, disrupted cerebrospinal fluid dynamics, and potential cranial nerve involvement
Personalize your experience
Follow Meningeal leukemia and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.